GEESLIN KEITH 4
4 · SYNAPTICS Inc · Filed Sep 11, 2023
Insider Transaction Report
Form 4
SYNAPTICS IncSYNA
GEESLIN KEITH
Director
Transactions
- Exercise/Conversion
Director Stock Option ( Right to Buy)
2023-09-07−2,900→ 0 totalExercise: $52.57Exp: 2023-10-28→ Common Stock (2,900 underlying) - Exercise/Conversion
Common Stock
2023-09-07$52.57/sh+2,900$152,453→ 32,746 total
Footnotes (1)
- [F1]1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2016 date of grant, until fully vested on October 28, 2017.